Hologic acquires Mobidiag for $795M

By LabPulse.com staff writers

April 8, 2021 -- Hologic announced it has agreed to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation.

The deal includes a cash payment of approximately $714 million for Mobidiag's equity and net debt of approximately $81 million.

Mobidiag develops and markets polymerase chain reaction (PCR)-based tests for acute care conditions such as gastrointestinal and respiratory infections, antimicrobial resistance management, and healthcare-associated infections. The Amplidiag and Novodiag platforms are automated instruments that deliver rapid turnaround times ranging from 50 minutes to two hours.

Mobidiag generated approximately $42 million in revenue in calendar year 2020. Hologic said it intends to invest in assay development to drive growth of the Novodiag platform.

Hologic acquires Diagenode for $159 million
Hologic has purchased European molecular diagnostic assay and epigenetic product developer Diagenode for $159 million in a deal that will expand...
Hologic wraps up Biotheranostics acquisition
Hologic has completed the acquisition of cancer test developer Biotheranostics. Hologic is gaining access to two laboratory-developed tests as part of...
Hologic inks deal with Google to unite cloud with diagnostics
Hologic has announced a collaboration with Google designed to advance the potential of digital diagnostics for cervical cancer screening by making Google...
Diagnostics growth drives Hologic's Q1 results higher
Strong growth in its molecular diagnostics business -- with revenues almost tripling due to the COVID-19 pandemic -- helped drive first-quarter preliminary...
Mobidiag, Autobio plan 30-minute coronavirus test
Mobidiag of Finland and Autobio Diagnostics of China are developing a rapid test for the novel coronavirus (2019-nCoV) and influenza viruses that they...

Copyright © 2021 LabPulse.com

Last Updated np 4/8/2021 2:21:15 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current